Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02881242
Title Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

prostate cancer

Therapies

Trametinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.